Acknowledgments This report summarizes the meeting on “Improving Priority Antibiotic Access in Thailand and Regional Coordinated Procurement Mechanisms,” held on 7–8 July 2025 in Bangkok, Thailand. The meeting was convened by the Health Intervention and Technology Assessment Program Foundation (HIT

Chee Ern is a research assistant at MIDAS and a recent graduate from the National University of Singapore, with a bachelor’s degree in Pharmaceutical Sciences. She maintains a keen interest in public health and is passionate about improving patient access to innovative and effective health interventions through health economics and outcomes researc

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

Dr. Nishanta Sharma is a quantitative researcher at HITAP Thailand, currently leading a project that assesses the environmental and economic impacts of low-value healthcare services using input-output analysis, as well as exploring the nexus between climate and epidemiology. He holds a PhD in Development and Sustainability from the Asian Institute

Jarawee Sukmanee is a researcher at the Health Intervention and Technology Assessment Program Foundation (HITAP). With a background as a medical doctor and epidemiologist, she applies advanced analytical techniques to evaluate the cost-effectiveness of health interventions. She plays a key role in generating evidence to support national policy deci

Economic evaluation of HLA-B*1502 screening for preventing carbamazepine- induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is prioritized by stakeholders under ‘Research for development of health benefit package under universal coverage scheme’. The study carried out an evidence to inform the Subcommittee for Developm

Introduction: The development of new technology to treat patients with metastatic renal cell carcinoma has resulted in promising outcomes in terms of extending life and improving quality of life. In Thailand, where health resources are limited, an economic evaluation of such technology would provide useful information for pricing and reimbursement

HITAP, in collaboration with the Center for the Evaluation of Value and Risk in Health, Tufts Medical Cent, conducted an analysis of existing capacity for conducting economic evaluations in the African region using the Tufts Medical Center CEA Registries. The findings of the study were presented at the PMAC 2020 side meeting “Attain & Sustain

The Prince Mahidol Award Conference (PMAC) is an annual international conference focusing on policy-related health issues. PMAC is co-hosted by the Prince Mahidol Award Foundation with support from other key related partners. In 2021, HITAP has led one webinar session and co-led two others with international partners. For more information, please v

HTAsiaLink is a collaborative research network of Health Technology Assessment (HTA) agencies in the Asia-Pacific region established on September 2010. The network started with an aim to strengthen Health Technology Assessment (HTA) research efficiency by sharing HTA information, experiences, and resources within the members. HTAsiaLink also focuse